{"id":"W3207946669","doi":"10.1001/jamacardio.2021.4027","title":"Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure","year":2021,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Internal medicine; Placebo; Randomized controlled trial; Clinical endpoint; Cardiology; Population; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00201671,0.0005318723,0.00144582,0.0002682081,0.0002103397,0.0005056754,0.0003979118,0.0007171401,0.003737832],"category_scores_gemma":[0.002719857,0.0002234715,0.001212281,0.0002543598,0.0003846967,0.0005017808,0.0003477716,0.001165402,0.0002775267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002666815,"about_ca_system_score_gemma":0.0004804151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000250027,"about_ca_topic_score_gemma":0.0007688382,"domain_scores_codex":[0.9990712,0.0006127446,0.00009390381,0.00008655892,0.00008222908,0.00005337538],"domain_scores_gemma":[0.998589,0.0004179775,0.0005643768,0.00005929898,0.0001046171,0.0002647624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8224784,0.004344088,0.0139864,0.002945734,0.002667363,0.0001207166,0.00009763054,0.0005388903,0.009256677,0.0002335498,0.001756855,0.1415736],"study_design_scores_gemma":[0.6133845,0.3131287,0.06001899,0.000500927,0.003562795,0.0002998584,0.00009954084,0.001093495,0.002568752,0.0003743914,0.004921713,0.00004636042],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.959374,0.03204466,0.0007558598,0.001419791,0.0003126847,0.001970095,0.0008878899,0.00006165235,0.003173326],"genre_scores_gemma":[0.9943592,0.003038895,0.0007385718,0.0005308179,0.0001663187,0.0005675445,0.0002610026,0.000002603401,0.0003350168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003737832,"threshold_uncertainty_score":0.01250434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01275077624360513,"score_gpt":0.2761355849483731,"score_spread":0.2633848087047679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}